XML 59 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Reporting (Tables)
 12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
The following table is a reconciliation of the Company’s business segments to the consolidated financial statements: 
In millions
Pharmacy Services
Segment(1)(2)
 
Retail/LTC
Segment(2)
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
2015:
 

 
 

 
 

 
 

 
 

Net revenues
$
100,363

 
$
72,007

 
$
—

 
$
(19,080
)
 
$
153,290

Gross profit
5,227

 
21,992

 
—

 
(691
)
 
26,528

Operating profit(3)
3,989

 
7,130

 
(1,037
)
 
(628
)
 
9,454

Depreciation and amortization
654

 
1,336

 
102

 
—

 
2,092

Additions to property and equipment
359

 
1,883

 
125

 
—

 
2,367

2014:
 

 
 

 
 

 
 

 
 

Net revenues
$
88,440

 
$
67,798

 
$
—

 
$
(16,871
)
 
$
139,367

Gross profit
4,771

 
21,277

 
—

 
(681
)
 
25,367

Operating profit
3,514

 
6,762

 
(796
)
 
(681
)
 
8,799

Depreciation and amortization
630

 
1,205

 
96

 
—

 
1,931

Additions to property and equipment
308

 
1,745

 
83

 
—

 
2,136

2013:
 

 
 

 
 

 
 

 
 

Net revenues
$
76,208

 
$
65,618

 
$
—

 
$
(15,065
)
 
$
126,761

Gross profit
4,237

 
20,112

 
—

 
(566
)
 
23,783

Operating profit(4)
3,086

 
6,268

 
(751
)
 
(566
)
 
8,037

Depreciation and amortization
560

 
1,217

 
93

 
—

 
1,870

Additions to property and equipment
313

 
1,610

 
61

 
—

 
1,984

 
(1)
Net revenues of the Pharmacy Services Segment include approximately $8.9 billion, $8.1 billion and $7.9 billion of Retail Co-Payments for 2015, 2014 and 2013, respectively. See Note 1 to the consolidated financial statements for additional information about Retail Co-Payments. 
(2)
Intersegment eliminations relate to intersegment revenue generating activities that occur between the Pharmacy Services Segment and the Retail/LTC Segment. These occur in the following ways: when members of Pharmacy Services Segment clients (“members”) fill prescriptions at retail stores to purchase covered products, when members enrolled in programs such as Maintenance Choice® elect to pick up maintenance prescriptions at a retail drugstore instead of receiving them through the mail, or when members have prescriptions filled at long-term care facilities. When these occur, both the Pharmacy Services and Retail/LTC segments record the revenues, gross profit and operating profit on a standalone basis.
(3)
For the year ended December 31, 2015, the Corporate Segment operating loss includes $156 million of acquisition-related transaction and integration costs and a $90 million charge related to a legacy lawsuit challenging the 1999 legal settlement by MedPartners of various securities class actions and a related derivative claim.
(4)
Consolidated operating profit for the year ended December 31, 2013 includes a $72 million gain on a legal settlement, of which, $11 million is included in the Pharmacy Services Segment and $61 million is included in the Retail/LTC Segment.